Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...

Non-profit arm of the de-extinction company secures an additional $50 million, expands global projects and partnerships, and ...

Learn how to get the vaccines you need now to protect yourself from illnesses, including flu, RSV, measles, Covid-19, and ...

U.S. health agencies led by Health and Human Services Secretary Robert F. Kennedy Jr., were beset by multiple controversies ...

Collaboration to leverage CAMP4’s RAP Platform® to accelerate development of novel antisense oligonucleotides (ASOs) for neurodegenerative and ...

Internationally recognized for its research institutes, including the Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute, Kanazawa University promotes interdisciplinary ...

Collaboration to leverage CAMP4's RAP Platform® to accelerate development of novel antisense oligonucleotides (ASOs) for neurodegenerative and renal diseases CAMP4 to receive $17.5 million upfront and ...

Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw ...

The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...